B+
Bull case
25%
Probability
Target price
$13.00
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex
RGNX
REGENXBIODNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
RGX-202 remains the principal value driver, with BLA progress and potential accelerated approval, while wet AMD data could add upside. The company also reported pro forma liquidity above $310 million and runway into Q4 2027.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +11.5.
What can break
Binary readout risk for Q4 2026 wet AMD pivotal data.
Momentum
10
Value
41
Sentiment
50
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $7.00 · Bull $13.00 · Bear $4.50Analysis 2026-08-25; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-25 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $22.09
Why
Momentum10 · Δ7d -9.1
Value41 · Δ7d 0.0
Sentiment50 · Δ7d +11.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +11.5.
Contradictions & invalidation
- • Binary readout risk for Q4 2026 wet AMD pivotal data.
- • Binary regulatory and clinical risk around RGX-202 BLA progression and potential approval.
- • The RGX-121 clinical hold removes or delays a meaningful pipeline asset and the company does not expect a near-term BLA resubmission.
Catalyst clock
2026-08-24
RGX-121 FDA clinical hold and near-term BLA delay
Lead driver: Sentiment · See AI snapshot
Momentum
10
9% active weight
Current posture
7d trendSoftening
Δ7d
-9.1
Δ21d
-58.0
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
50
62% active weight
Current posture
7d trendImproving
Δ7d
+11.5
Δ21d
-16.2
Why this grade
Composite grade D. Momentum 10.0 / Value 41.2 / Sentiment 49.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-25. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$7.00
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$747.93M
Beta
1.06
Shares Out
66.01M
P/E (TTM) · Derived
-3.0
P/S (TTM)
4.21
P/FCF (TTM) · Derived
-2.37
Rev YoY
+405.7%
EPS YoY
-131.1%
Gross Margin
+77.6%
Op Margin
-94.1%
Net Debt
$30.45M
Current Ratio
2.86
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data